Simple Summary Lung cancer and in particular non-small cell lung cancer (NSCLC)
remains the leading cause of cancer-related death. The development of new therapeutic …

The diagnosis, staging and therapeutic monitoring of lung cancer were amongst the first
applications for which the utility of FDG PET was documented and FDG PET/CT is now a …

Simple Summary Positron-emission tomography/computed tomography (PET/CT) is used for
staging of non-small cell lung cancer (NSCLC) and can help to estimate prognosis in …

Simple Summary Lung cancer is the leading cause of cancer-related death worldwide.
Nonsmall cell lung cancer (NSCLC) accounts for 80–85% of all cases. Immune checkpoint …

Simple Summary Identifying reliable prognostic biomarkers of progression in the early
phases of treatment is crucial in patients undergoing immune checkpoints inhibitors (ICI) …

Purpose Because of atypical response imaging patterns in patients with metastatic non-
small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new …

Introduction: The aim of this study was to investigate whether [18F] FDG PET/CT-derived
semi-quantitative parameters can predict immunotherapy treatment response in non-small …

The immune checkpoint inhibitors (ICIs), by targeting cytotoxic-T-lymphocyte-associated
protein 4, programmed cell death 1 (PD-1), or PD-ligand 1, have dramatically changed the …

Background The purpose of this study was to investigate the predictive value of tumor
metabolic parameters in combination with secondary lymphoid metabolic parameters on …

Lung cancer is a malignant tumour originating from the bronchial epithelium or glands of the
lung with high morbidity and mortality. For advanced lung cancer, the lack of effective …